LRDJF yields 2369.67% · JNJ yields 2.13%● Live data
📍 LRDJF pulled ahead of the other in Year 1
Combined, LRDJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LRDJF + JNJ for your $10,000?
St. James Gold Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral resource properties in Canada. The company primarily explores for gold deposits. It has an option to acquire a 100% interest in Grub line property comprises 29 claims covering an area of 1,791 acres located in the Gander gold district in north-central Newfoundland; and the Quinn lake property consisting of two contiguous mineral licenses totaling 700 hectares situated in the west-central region of the Island of Newfoundland, as well as has an option to acquire 85% interest in the Florin gold project located in the Yukon Territory, Canada. The company was formerly known as Bard Ventures Ltd. and changed its name to St. James Gold Corp. in October 2020. St. James Gold Corp. was founded in 1981 and is headquartered in Vancouver, Canada.
Full LRDJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.